LD-2 disclosure · 2nd Quarter - Report
SHIRE PHARMACEUTICALS, INC
Client
- Description
- Biopharmaceutical company
- Location
- Pennsylvania · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Prepare advocacy materials to be used for lobbying on issues related to development of drugs for rare diseases, reimbursement of products, and FDA review and approval of biosimilars, products for rare diseases and other conditions. Prepared materials regarding S. 296, Preserving Access to Life Saving Medicines Act.
LobbyistsMICHAEL WERNER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Medical/Disease Research/Clinical Labs
Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases.
LobbyistsMICHAEL WERNER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)